Webcasting The New Norm During COVID-19 As FDA Reschedules Opthalmic AdComm Panel
In a sign of the times, regulators are holding an advisory committee meeting for an ophthalmic device online because of the pandemic.
You may also be interested in...
For the second time in the past few months the US agency has rescheduled a webcast of a public meeting meant to start MDUFA V user-fee negotiations.
In a sign the US FDA is trying to address key issues not related to COVID-19, the agency is bringing together an expert panel almost five months after it was originally slated to meet to discuss classifying a slew of orthopedic devices.
The US agency had planned to hold an in-person meeting of its ophthalmic advisory committee in early June, indicating hope that things would be back to some form of normal by then. But due to the ongoing coronavirus pandemic, it has postponed that meeting until further notice.